Value of sequencing-guided treatment for patients with advanced malignancies.
Casey Williams(Creighton University), Brian Leyland‐Jones(Avera Health), Bing Xu(First Affiliated Hospital of Xiamen University), Amy Krie(Amgen (United States)), Amanda McMillan(Avera Health), Kirstin Williams(Avera Health), Robert B. Goldberg(Trillium Health Centre), Luis A. Rojas(Institut de Seguretat Pública de Catalunya), David Starks(Cleveland Clinic), Benjamin Solomon(Avera Health), Ping Ye(Avera Health), Pradip De(Avera Health), Rachel Elsey(Cancer Institute (WIA)), Jessica Klein(Cancer Institute (WIA)), Nandini Dey(University of South Dakota)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726